Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT05163886
Previous Study | Return to List | Next Study

Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT05163886
Recruitment Status : Active, not recruiting
First Posted : December 20, 2021
Last Update Posted : August 12, 2022
Information provided by (Responsible Party):
AI Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 10, 2022
Estimated Study Completion Date : September 10, 2023